PIERIS PHARMACEUTICALS, INC.·4

Jun 24, 7:04 PM ET

Said Maya R. 4

4 · PIERIS PHARMACEUTICALS, INC. · Filed Jun 24, 2022

Insider Transaction Report

Form 4
Period: 2022-06-22
Said Maya R.
Director
Transactions
  • Award

    Stock Option (right to buy)

    2022-06-22+40,00040,000 total
    Exercise: $1.82Exp: 2032-06-22Common Stock (40,000 underlying)
Footnotes (1)
  • [F1]The stock option will vest as to 100% of the underlying shares on the date of the Company's 2023 annual stockholders meeting, subject to the Reporting Person's continued service as a director through the vesting date.

Documents

1 file
  • 4
    wf-form4_165611183103804.xmlPrimary

    FORM 4